Interleukin-2-fc fusion proteins and methods of use
MYPI2025003149A0Undetermined Publication Date: 2022-04-22GILEAD SCIENCES INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025003149
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-04-28
- Filing Date
- 2021-10-20
- Publication Date
- 2022-04-22
Abstract
INTERLEUKIN-2-Fc FUSION PROTEINS AND METHODS OF USE Provided are serum half-life extended-IL-2 variant (IL-2v) heterodimers having reduced binding to the IL2Rα (CD25) subunit. In particular, Fc-IL-2v heterodimers are provided and methods for making and using, e.g. for enhancing an immune response, e.g. in the prevention and treatment of viral infections and cancer. Figure 19
Need to check novelty before this filing date? Find Prior Art
